SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

PolyPid Regains European Rights for D-PLEX100

PolyPid Ltd. announced it has regained the European commercialization rights for its D-PLEX100 product from ADVANZ PHARM. This move expands the company's global commercialization opportunities.

PYPD